167 related articles for article (PubMed ID: 2943291)
1. Complement C3b receptors on erythrocytes, circulating immune complexes, and complement C3 split products in patients with primary Sjögren's syndrome.
Thomsen BS; Oxholm P; Manthorpe R; Nielsen H
Arthritis Rheum; 1986 Jul; 29(7):857-62. PubMed ID: 2943291
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte complement C3b receptor (CR1) levels and immune complex-induced manifestations in patients with primary Sjögren's syndrome.
Thomsen BS; Oxholm P; Nielsen H; Manthorpe R
Scand J Rheumatol Suppl; 1986; 61():127-30. PubMed ID: 2954207
[TBL] [Abstract][Full Text] [Related]
4. Complement C3b receptors on erythrocytes in patients with juvenile rheumatoid arthritis.
Thomsen BS; Heilmann C; Jacobsen SE; Pedersen FK; Morling N; Jakobsen BK; Svejgaard A; Nielsen H
Arthritis Rheum; 1987 Sep; 30(9):967-71. PubMed ID: 2959290
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte CR1 (C3b/C4b receptor) levels and disease activity in patients with SLE.
Thomsen BS; Nielsen H; Andersen V
Scand J Rheumatol; 1987; 16(5):339-46. PubMed ID: 2961056
[TBL] [Abstract][Full Text] [Related]
6. Levels of complement receptor type one (CR1, CD35) on erythrocytes, circulating immune complexes and complement C3 split products C3d and C3c are not changed by short-term physical exercise or training.
Thomsen BS; Rødgaard A; Tvede N; Hansen FR; Steensberg J; Halkjaer Kristensen J; Pedersen BK
Int J Sports Med; 1992 Feb; 13(2):172-5. PubMed ID: 1555909
[TBL] [Abstract][Full Text] [Related]
7. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
8. Loss of erythrocyte complement receptors (CR1; CD35) in patients with acute episodes of septicaemia or bacterial meningitis.
Olesen B; Thomsen BS; Kristensen HS
Scand J Infect Dis; 1992; 24(2):189-95. PubMed ID: 1641596
[TBL] [Abstract][Full Text] [Related]
9. Immune complex binding to erythrocyte-CR1 (CD 35), CR1 expression and levels of erythrocyte-fixed C3 fragments in SLE outpatients.
Jepsen HH; Møller Rasmussen J; Teisner B; Schrøder L; Holmskov U; Jarlbaek L; Isager H; Svehag SE
APMIS; 1990 Jul; 98(7):637-44. PubMed ID: 2144431
[TBL] [Abstract][Full Text] [Related]
10. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
Medof ME; Iida K; Mold C; Nussenzweig V
J Exp Med; 1982 Dec; 156(6):1739-54. PubMed ID: 7175439
[TBL] [Abstract][Full Text] [Related]
11. Interaction of complement-solubilized immune complexes with CR1 receptors on human erythrocytes. The binding reaction.
Jepsen HH; Svehag SE; Jarlbaek L; Baatrup G
Scand J Immunol; 1986 Jan; 23(1):65-73. PubMed ID: 2939551
[TBL] [Abstract][Full Text] [Related]
12. Identification of the C3b receptor-binding domain in third component of complement.
Becherer JD; Lambris JD
J Biol Chem; 1988 Oct; 263(28):14586-91. PubMed ID: 2971659
[TBL] [Abstract][Full Text] [Related]
13. Erythrocytes from young but not elderly donors can bind and degrade immune complex- and antibody-bound C3 in vitro.
Shapiro S; Kohn D; Miller B; Gershon H
Clin Exp Immunol; 1994 Jan; 95(1):181-90. PubMed ID: 8287603
[TBL] [Abstract][Full Text] [Related]
14. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
Paccaud JP; Carpentier JL; Schifferli JA
Eur J Immunol; 1990 Feb; 20(2):283-9. PubMed ID: 2138082
[TBL] [Abstract][Full Text] [Related]
15. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.
Tausk FA; McCutchan A; Spechko P; Schreiber RD; Gigli I
J Clin Invest; 1986 Oct; 78(4):977-82. PubMed ID: 2944915
[TBL] [Abstract][Full Text] [Related]
16. Glomerular CR1 express in situ cofactor activity for degradation of C3b.
Vedeler CA; Matre R; Iversen BM
Int Arch Allergy Appl Immunol; 1990; 92(1):60-3. PubMed ID: 2147176
[TBL] [Abstract][Full Text] [Related]
17. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon.
Kumar A; Kumar A; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
Immunol Cell Biol; 1995 Oct; 73(5):457-62. PubMed ID: 8595925
[TBL] [Abstract][Full Text] [Related]
18. IgA rheumatoid factor and IgA containing immune complexes in primary Sjögren's syndrome.
Atkinson JC; Fox PC; Travis WD; Popek E; Katz RW; Balow JE; Pillemer SR
J Rheumatol; 1989 Sep; 16(9):1205-10. PubMed ID: 2810277
[TBL] [Abstract][Full Text] [Related]
19. Immune complexes in Sjögren's syndrome.
Fischbach M; Char D; Christensen M; Daniels T; Whaley K; Alspaugh M; Talal N
Arthritis Rheum; 1980 Jul; 23(7):791-5. PubMed ID: 6902669
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
Wilson JG; Ratnoff WD; Schur PH; Fearon DT
Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
